https://cloud.google.com/blog/products/infrastructure-modernization/introducing-blockchain-node-engine
Matinas BioPharma Updates on MAT2203 Regulatory and Development Pathway Following Feedback from FDA
Matinas BioPharma Holdings, Inc. (NYSE:MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform technology, announces receipt of
